The latest application of feed grade antibiotics in Europe (8.24)
-
Last Update: 2003-03-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
OA show ('918 '); since June 1999, the EU has banned the use of sub therapeutic levels of norrimycin, tylosin phosphate and zinc bacitracin as growth promoters in animal feed In October 1999, the European Union banned the application of three kinds of anticoccidial drugs, namely, chlorofluorobenzyladenine, dinitrotoluenamide and ipratrodazole, in feed In addition to several widely used anticoccidial agents, the permitted feeds and antibiotics are: monensin (monensin sodium), salinomycin (salinomycin sodium), babomicin and pycnomycin The European Commission believes that the importance of these four antibiotics in human medicine is not significant, so the problem of drug resistance of human pathogens is not considered Pfizer, which makes norrimycin, has taken legal action against EU and Danish bans, and other drug manufacturers are considering similar actions Countries outside the European Union have also been affected by the ban, Canada has complained that the ban issued by the European Commission has no scientific basis, and EU trading partners have begun to worry that restrictions on feed antibiotics in world trade also apply to their products In any case, feed producers in the EU cannot expect these bans to be lifted quickly, at least by the end of 2000 They are expanding the use of a range of non drug growth promoters These additives include organic acids, enzyme preparations, directly fed microbial preparations and plant extracts from "plants" Functional foods and homeopathy for human use also start from animal feed M2e (author:)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.